REG - Iofina PLC - Result of AGM

IofinaAnnouncement

22/06/2022 14:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220622:nRSV8393Pa&default-theme=true

RNS Number : 8393P  Iofina PLC  22 June 2022

22 June 2022

 

Iofina Plc

("Iofina" or the "Company")

(LSE AIM: IOF)

 

Result of Annual General Meeting

 

Iofina plc, manufacturers of specialty chemical products and specialists in
the exploration and production of iodine, announces that at its Annual General
Meeting ("AGM") held at 10:00 a.m. on Wednesday 22 June 2022 all resolutions
put to the meeting, were duly passed.

 

The full text of the resolutions considered at the AGM are contained in the
Notice of AGM which is available on the Company's website at www.iofina.com
(http://www.iofina.com) .

 

 

Enquiries:

 

Dr. Tom Becker

CEO & President

Iofina plc

Tel: +1 859 356 8000

 

Christopher Raggett/Tim Harper (Corporate Finance)

Tim Redfern/Barney Hayward (ECM)

finnCap Ltd

Tel: +44 (0)20 7220 0500

 

Kingsley Wilson

Chrystal Capital Partners LLP

Tel: +44 (0)20 7850 4760

 

Media Contact:

Charles Goodwin/Laurie Gelhorn

Yellow Jersey PR Limited

Tel: +44 (0)7747 788 221

About Iofina:

www.iofina.com (http://www.iofina.com)

 

Iofina plc (AIM: IOF) is a vertically integrated Company that specialises in
the production of Iodine and the manufacturing of specialty chemical products.
Iofina is the second largest producer of iodine in North America and operates
the manufacturing entities Iofina Resources and Iofina Chemical.

 

LEI: 213800QDMFYVRJYYTQ84

ISIN: GB00B2QL5C79

 

Iofina Resources

Iofina Resources develops, builds, owns and operates iodine extraction plants
using Iofina's WET® IOsorb® technology. Iofina currently operates five
producing IOsorb® plants in Oklahoma and is consistently using technology and
innovation to improve and expand its operations.

 

Iofina Chemical

Iofina Chemical has manufactured high quality halogen specialty chemicals
derived from raw iodine, as well as non-iodine based products for over 38
years.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGSEWFDEEESEFM